Advertisement

Current Psychiatry Reports

, 11:12 | Cite as

Some new food for thought: The role of vitamin D in the mental health of older adults

  • E. Paul Cherniack
  • Bruce R. Troen
  • Hermes J. Florez
  • Bernard A. Roos
  • Silvina Levis
Article

Abstract

Vitamin D, a multipurpose steroid hormone vital to health, has been increasingly implicated in the pathology of cognition and mental illness. Hypovitaminosis D is prevalent among older adults, and several studies suggest an association between hypovitaminosis D and basic and executive cognitive functions, depression, bipolar disorder, and schizophrenia. Vitamin D activates receptors on neurons in regions implicated in the regulation of behavior, stimulates neurotrophin release, and protects the brain by buffering antioxidant and anti-inflammatory defenses against vascular injury and improving metabolic and cardiovascular function. Although additional studies are needed to examine the impact of supplementation on cognition and mood disorders, given the known health benefits of vitamin D, we recommend greater supplementation in older adults.

Keywords

Serum Vitamin Nutr Health Aging Seasonal Affective Disorder Seasonal Affective Disorder Executive Cognitive Function 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References and Recommended Reading

  1. 1.
    Autier P, Gandini S: Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med 2007, 167:1730–1737.PubMedCrossRefGoogle Scholar
  2. 2.
    Visser M, Deeg DJ, Puts MT, et al.: Low serum concentrations of 25-hydroxyvitamin D in older persons and the risk of nursing home admission. Am J Clin Nutr 2006, 84:616–622; quiz 671–672.PubMedGoogle Scholar
  3. 3.
    Melamed ML, Michos ED, Post W, Astor B: 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med 2008, 168:1629–1637.PubMedCrossRefGoogle Scholar
  4. 4.
    Cherniack EP, Florez H, Roos BA, et al.: Hypovitaminosis D in the elderly: from bone to brain. J Nutr Health Aging 2008, 12:366–373.CrossRefGoogle Scholar
  5. 5.
    Levis S, Gomez A, Jimenez C, et al.: Vitamin D deficiency and seasonal variation in an adult south Florida population. J Clin Endocrinol Metab 2005, 90:1557–1562.PubMedCrossRefGoogle Scholar
  6. 6.
    Buell JS, Dawson-Hughes B: Vitamin D and neurocognitive dysfunction: preventing “D”ecline? Mol Aspects Med 2008, 29:415–422.PubMedCrossRefGoogle Scholar
  7. 7.
    Riddle DR: Brain Aging: Models, Methods, and Mechanisms. Boca Raton, FL: CRC Press; 2007.Google Scholar
  8. 8.
    Przybelski RJ, Binkley NC: Is vitamin D important for preserving cognition? A positive correlation of serum 25-hydroxyvitamin D concentration with cognitive function. Arch Biochem Biophys 2007, 460:202–205.PubMedCrossRefGoogle Scholar
  9. 9.
    Oudshoorn C, Mattace-Raso FU, van der Velde N, et al.: Higher serum vitamin D3 levels are associated with better cognitive test performance in patients with Alzheimer’s disease. Dement Geriatr Cogn Disord 2008, 25:539–543.PubMedCrossRefGoogle Scholar
  10. 10.
    Rondanelli M, Trotti R, Opizzi A, Solerte SB: Relationship among nutritional status, pro/antioxidant balance and cognitive performance in a group of free-living healthy elderly. Minerva Med 2007, 98:639–645.PubMedGoogle Scholar
  11. 11.
    Wilkins CH, Sheline YI, Roe CM, et al.: Vitamin D deficiency is associated with low mood and worse cognitive performance in older adults. Am J Geriatr Psychiatry 2006, 14:1032–1040.PubMedCrossRefGoogle Scholar
  12. 12.
    Roth RM, Isquith PK, Gioia GA: Assessment of and intervention for executive dysfunction. In Psychologist’s Desk Reference, edn 2. Edited by Koocher GP, Norcross JC, Hill SS. New York: Oxford University Press; 2005:38–41.Google Scholar
  13. 13.
    Scott TM, Peter I, Tucker KL, et al.: The Nutrition, Aging, and Memory in Elders (NAME) study: design and methods for a study of micronutrients and cognitive function in a homebound elderly population. Int J Geriatr Psychiatry 2006, 21:519–528.PubMedCrossRefGoogle Scholar
  14. 14.
    McGrath J, Scragg R, Chant D, et al.: No association between serum 25-hydroxyvitamin D3 level and performance on psychometric tests in NHANES III. Neuroepidemiology 2007, 29:49–54.PubMedCrossRefGoogle Scholar
  15. 15.
    Jorde R, Waterloo K, Saleh F, et al.: Neuropsychological function in relation to serum parathyroid hormone and serum 25-hydroxyvitamin D levels. The Tromso study. J Neurol 2006, 253:464–470.PubMedCrossRefGoogle Scholar
  16. 16.
    Hoogendijk WJ, Lips P, Dik MG, et al.: Depression is associated with decreased 25-hydroxyvitamin D and increased parathyroid hormone levels in older adults. Arch Gen Psychiatry 2008, 65:508–512.PubMedCrossRefGoogle Scholar
  17. 17.
    Berk M, Sanders KM, Pasco JA, et al.: Vitamin D deficiency may play a role in depression. Med Hypotheses 2007, 69:1316–1319.PubMedCrossRefGoogle Scholar
  18. 18.
    McGrath J: Hypothesis: is low prenatal vitamin D a risk-modifying factor for schizophrenia? Schizophr Res 1999, 40:173–177.PubMedCrossRefGoogle Scholar
  19. 19.
    McGrath J, Saari K, Hakko H, et al.: Vitamin D supplementation during the first year of life and risk of schizophrenia: a Finnish birth cohort study. Schizophr Res 2004, 67:237–245.PubMedCrossRefGoogle Scholar
  20. 20.
    Schaffer A, Levitt AJ, Boyle M: Influence of season and latitude in a community sample of subjects with bipolar disorder. Can J Psychiatry 2003, 48:277–280.PubMedGoogle Scholar
  21. 21.
    Armstrong DJ, Meenagh GK, Bickle I, et al.: Vitamin D deficiency is associated with anxiety and depression in fibromyalgia. Clin Rheumatol 2007, 26:551–554.PubMedCrossRefGoogle Scholar
  22. 22.
    Gloth FM 3rd, Alam W, Hollis B: Vitamin D vs broad spectrum phototherapy in the treatment of seasonal affective disorder. J Nutr Health Aging 1999, 3:5–7.PubMedGoogle Scholar
  23. 23.
    Lansdowne AT, Provost SC: Vitamin D3 enhances mood in healthy subjects during winter. Psychopharmacology (Berl) 1998, 135:319–323.CrossRefGoogle Scholar
  24. 24.
    Harris S, Dawson-Hughes B: Seasonal mood changes in 250 normal women. Psychiatry Res 1993, 49:77–87.PubMedCrossRefGoogle Scholar
  25. 25.
    Eyles D, Brown J, Mackay-Sim A, et al.: Vitamin D3 and brain development. Neuroscience 2003, 118:641–653.PubMedCrossRefGoogle Scholar
  26. 26.
    Dumville JC, Miles JN, Porthouse J, et al.: Can vitamin D supplementation prevent winter-time blues? A randomised trial among older women. J Nutr Health Aging 2006, 10:151–153.PubMedGoogle Scholar
  27. 27.
    Pasco JA, Henry MJ, Nicholson GC, et al.: Vitamin D status of women in the Geelong Osteoporosis Study: association with diet and casual exposure to sunlight. Med J Aust 2001, 175:401–405.PubMedGoogle Scholar
  28. 28.
    Torrey EF, Torrey BB, Peterson MR: Seasonality of schizophrenic births in the United States. Arch Gen Psychiatry 1977, 34:1065–1070.PubMedGoogle Scholar
  29. 29.
    Jarvis E: Schizophrenia in British immigrants: recent findings, issues and implications. Transcult Psychiatry 1998, 35:39–74.CrossRefGoogle Scholar
  30. 30.
    Ziegler EE, Hollis BW, Nelson SE, Jeter JM: Vitamin D deficiency in breastfed infants in Iowa. Pediatrics 2006, 118:603–610.PubMedCrossRefGoogle Scholar
  31. 31.
    Kalueff AV, Tuohimaa P: Neurosteroid hormone vitamin D and its utility in clinical nutrition. Curr Opin Clin Nutr Metab Care 2007, 10:12–19.PubMedCrossRefGoogle Scholar
  32. 32.
    Burne TH, McGrath JJ, Eyles DW, Mackay-Sim A: Behavioural characterization of vitamin D receptor knockout mice. Behav Brain Res 2005, 157:299–308.PubMedCrossRefGoogle Scholar
  33. 33.
    Kuningas M, Mooijaart SP, Jolles J, et al.: VDR gene variants associate with cognitive function and depressive symptoms in old age. Neurobiol Aging 2007 Aug 20 (Epub ahead of print).Google Scholar
  34. 34.
    Gezen-Ak D, Dursun E, Ertan T, et al.: Association between vitamin D receptor gene polymorphism and Alzheimer’s disease. Tohoku J Exp Med 2007, 212:275–282.PubMedCrossRefGoogle Scholar
  35. 35.
    Wion D, MacGrogan D, Neveu I, et al.: 1,25-Dihydroxyvitamin D3 is a potent inducer of nerve growth factor synthesis. J Neurosci Res 1991, 28:110–114.PubMedCrossRefGoogle Scholar
  36. 36.
    Naveilhan P, Neveu I, Wion D, Brachet P: 1,25-Dihydroxyvitamin D3, an inducer of glial cell line-derived neurotrophic factor. Neuroreport 1996, 7:2171–2175.PubMedCrossRefGoogle Scholar
  37. 37.
    Landfield PW, Cadwallader-Neal L: Long-term treatment with calcitriol (1,25(OH)2 vit D3) retards a biomarker of hippocampal aging in rats. Neurobiol Aging 1998, 19:469–477.PubMedCrossRefGoogle Scholar
  38. 38.
    Brewer LD, Thibault V, Chen KC, et al.: Vitamin D hormone confers neuroprotection in parallel with downregulation of L-type calcium channel expression in hippocampal neurons. J Neurosci 2001, 21:98–108.PubMedGoogle Scholar
  39. 39.
    Zittermann A, Schleithoff SS, Koerfer R: Vitamin D and vascular calcification. Curr Opin Lipidol 2007, 18:41–46.PubMedCrossRefGoogle Scholar
  40. 40.
    Zittermann A, Schleithoff SS, Koerfer R: Putting cardiovascular disease and vitamin D insufficiency into perspective. Br J Nutr 2005, 94:483–492.PubMedCrossRefGoogle Scholar
  41. 41.
    Timms PM, Mannan N, Hitman GA, et al.: Circulating MMP9, vitamin D and variation in the TIMP-1 response with VDR genotype: mechanisms for inflammatory damage in chronic disorders? QJM 2002, 95:787–796.PubMedCrossRefGoogle Scholar
  42. 42.
    Cherniack EP, Troen BR: Calciotropic hormones. In Senile Osteoporosis: Advances in Pathophysiology and Therapeutic Approach. Edited by Duque G, Kiel DP. London: Springer-Verlag; 2008:34–46.Google Scholar
  43. 43.
    Judd SE, Nanes MS, Ziegler TR, et al.: Optimal vitamin D status attenuates the age-associated increase in systolic blood pressure in white Americans: results from the third National Health and Nutrition Examination Survey. Am J Clin Nutr 2008, 87:136–141.PubMedGoogle Scholar
  44. 44.
    Zittermann A, Schleithoff SS, Tenderich G, et al.: Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure? J Am Coll Cardiol 2003, 41:105–112.PubMedCrossRefGoogle Scholar
  45. 45.
    Li YC, Kong J, Wei M, et al.: 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 2002, 110:229–238.PubMedGoogle Scholar
  46. 46.
    Pfeifer M, Begerow B, Minne HW, et al.: Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. J Clin Endocrinol Metab 2001, 86:1633–1637.PubMedCrossRefGoogle Scholar
  47. 47.
    Heaney RP: Functional indices of vitamin D status and ramifications of vitamin D deficiency. Am J Clin Nutr 2004, 80(6 Suppl):1706S–1709S.PubMedGoogle Scholar
  48. 48.
    Heaney RP: The vitamin D requirement in health and disease. J Steroid Biochem Mol Biol 2005, 97:13–19.PubMedCrossRefGoogle Scholar
  49. 49.
    Cherniack EP, Florez H, Hollis B, et al.: High dose of vitamin D3 reduces the prevalence of hypovitaminosis D in elderly veterans. Gerontologist 2007, 47:13–14.Google Scholar
  50. 50.
    Vieth R: Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 1999, 69:842–856.PubMedGoogle Scholar
  51. 51.
    Ish-Shalom S, Salganik T, Segal E, et al.: Daily, weekly or monthly protocols to reach the desired serum 25-hydroxyvitamin D concentration for the elderly. J Bone Miner Res 2005, 20(Suppl 1):S288.Google Scholar
  52. 52.
    Mocanu V, Stitt PA, Costan A, et al.: Safety and bone mineral density effects of bread fortified with 125 mcg vitamin D3/day in Romanian nursing-home residents [abstract]. J Bone Miner Res 2005, 20(Suppl 1):S288.Google Scholar
  53. 53.
    Diamond TH, Ho KW, Rohl PG, Meerkin M: Annual intramuscular injection of a megadose of cholecalciferol for treatment of vitamin D deficiency: efficacy and safety data. Med J Aust 2005, 183:10–12.PubMedGoogle Scholar
  54. 54.
    Trang HM, Cole DE, Rubin LA, et al.: Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2. Am J Clin Nutr 1998, 68:854–858.PubMedGoogle Scholar
  55. 55.
    Armas LA, Hollis BW, Heaney RP: Vitamin D2 is much less effective than vitamin D3 in humans. J Clin Endocrinol Metab 2004, 89:5387–5391.PubMedCrossRefGoogle Scholar
  56. 56.
    Holick MF, Biancuzzo RM, Chen TC, et al.: Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D. J Clin Endocrinol Metab 2008, 93:677–681.PubMedCrossRefGoogle Scholar
  57. 57.
    Giovannucci E: The epidemiology of vitamin D and cancer incidence and mortality: a review (United States). Cancer Causes Control 2005, 16:83–95.PubMedCrossRefGoogle Scholar
  58. 58.
    Bischoff-Ferrari HA, Giovannucci E, Willett WC, et al.: Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 2006, 84:18–28.PubMedGoogle Scholar

Copyright information

© Current Medicine Group LLC 2009

Authors and Affiliations

  • E. Paul Cherniack
    • 1
  • Bruce R. Troen
  • Hermes J. Florez
  • Bernard A. Roos
  • Silvina Levis
  1. 1.Geriatrics Institute and Division of Gerontology and Geriatric Medicine, Miller School of MedicineUniversity of Miami, and GRECC and Research Service, Bruce W. Carter Department of Veterans Affairs Medical CenterMiamiUSA

Personalised recommendations